Abstract
Treatment-resistant depression often leads to increased morbidity and disability. The authors report the use of ketamine, a selective N-methyl-d-aspartate (NMDA) receptor antagonist, in two patients with treatment-resistant depression. Multiple ketamine treatments may provide an effective rapid antidepressant effect with prolonged benefit.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 442-444 |
| Number of pages | 3 |
| Journal | Journal of Neuropsychiatry and Clinical Neurosciences |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jan 1 2010 |
Fingerprint
Dive into the research topics of 'The use of a series of ketamine infusions in two patients with treatment-resistant depression'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS